Kim Blom

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: EMERGING INFECTIOUS DISEASES. 2023;29(6):1240-1243

High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022.

Groenheit R; Bacchus P; Galanis I; Sondén K; Bujila I; Efimova T; Garli F; Lindsjö OK; Mansjö M; Movert E; Pettke A; Rapp M; Sperk M; Söderholm S; Asin KV; Zanetti S; Karlberg ML; Bråve A; Blom K; Klingström J
Article: NATURE COMMUNICATIONS. 2023;14(1):1577

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers.

Marking U; Havervall S; Norin NG; Bladh O; Christ W; Gordon M; Ng H; Blom K; Phillipson M; Mangsbo S; Alm JJ; Smed-Sörensen A; Nilsson P; Hober S; Åberg M; Klingström J; Thålin C
Article: PLOS NEGLECTED TROPICAL DISEASES. 2023;17(2):e0010616

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial.

Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren H-G
Article: VACCINES. 2022;10(3):359

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.

Marking U; Havervall S; Greilert-Norin N; Ng H; Blom K; Nilsson P; Phillipson M; Hober S; Nilsson C; Mangsbo S; Christ W; Klingström J; Gordon M; Åberg M; Thålin C
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2022;11(4):e1388

Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.

Havervall S; Marking U; Greilert-Norin N; Gordon M; Ng H; Christ W; Phillipson M; Nilsson P; Hober S; Blom K; Klingström J; Mangsbo S; Åberg M; Thålin C
Article: JOURNAL OF IMMUNOLOGY. 2021;207(4):1033-1043

Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.

Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren H-G
Article: EBIOMEDICINE. 2021;70:103523

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.

Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson A-C; Hellström C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingström J; Hober S; Nilsson P; Åberg M; Thålin C
Article: CELL REPORTS. 2021;35(8):109174

Divergent clonal differentiation trajectories establish CD8+ memory T cell heterogeneity during acute viral infections in humans.

Mold JE; Modolo L; Hård J; Zamboni M; Larsson AJM; Stenudd M; Eriksson C-J; Durif G; Ståhl PL; Borgström E; Picelli S; Reinius B; Sandberg R; Réu P; Talavera-Lopez C; Andersson B; Blom K; Sandberg JK; Picard F; Michaëlsson J; Frisén J
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2021;10(7):e1306

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.

Sandberg JT; Varnaitė R; Christ W; Chen P; Muvva JR; Maleki KT; García M; Dzidic M; Folkesson E; Skagerberg M; Ahlén G; Frelin L; Sällberg M; Eriksson LI; Rooyackers O; Sönnerborg A; Buggert M; Björkström NK; Aleman S; Strålin K; Klingström J; Ljunggren H-G; Blom K; Gredmark-Russ S; Karolinska COVID‐19 Study Group
Article: JOURNAL OF IMMUNOLOGY. 2020;205(9):2437-2446

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.

Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren H-G; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
Article: JOURNAL OF IMMUNOLOGY. 2020;204(4):914-922

Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine.

Varnaitė R; Blom K; Lampen MH; Vene S; Thunberg S; Lindquist L; Ljunggren H-G; Rombo L; Askling HH; Gredmark-Russ S
Article: JOURNAL OF IMMUNOLOGY. 2019;203(8):2210-2221

Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity.

Naluyima P; Lal KG; Costanzo MC; Kijak GH; Gonzalez VD; Blom K; Eller LA; Creegan M; Hong T; Kim D; Quinn TC; Björkström NK; Ljunggren H-G; Serwadda D; Katabira ET; Sewankambo NK; Gray RH; Baeten JM; Michael NL; Wabwire-Mangen F; Robb ML; Bolton DL; Sandberg JK; Eller MA
Article: VACCINE. 2019;37(31):4401-4406

Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden.

Blom K; Yin L; Arnheim-Dahlström L
Article: IMMUNOHORIZONS. 2018;2(6):172-184

Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection.

Lampen MH; Uchtenhagen H; Blom K; Varnaitė R; Pakalniene J; Dailidyte L; Wälchli S; Lindquist L; Mickiene A; Michaëlsson J; Schumacher TN; Ljunggren H-G; Sandberg JK; Achour A; Gredmark-Russ S
Article: JOURNAL OF IMMUNOLOGY. 2016;197(7):2762-2771

NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection.

Blom K; Braun M; Pakalniene J; Lunemann S; Enqvist M; Dailidyte L; Schaffer M; Lindquist L; Mickiene A; Michaëlsson J; Ljunggren H-G; Gredmark-Russ S
Article: JOURNAL OF IMMUNOLOGY. 2015;195(7):3262-3272

The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education.

Marquardt N; Ivarsson MA; Blom K; Gonzalez VD; Braun M; Falconer K; Gustafsson R; Fogdell-Hahn A; Sandberg JK; Michaëlsson J
Article: PLOS PATHOGENS. 2015;11(1):e1004622

Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection.

Blom K; Braun M; Pakalniene J; Dailidyte L; Béziat V; Lampen MH; Klingström J; Lagerqvist N; Kjerstadius T; Michaëlsson J; Lindquist L; Ljunggren H-G; Sandberg JK; Mickiene A; Gredmark-Russ S
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2013;63(3):289-293

Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections.

Flach B; Naluyima P; Blom K; Gonzalez VD; Eller LA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Wawer MJ; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Eller MA; Sandberg JK
Article: JOURNAL OF IMMUNOLOGY. 2013;190(5):2150-2158

Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.

Blom K; Braun M; Ivarsson MA; Gonzalez VD; Falconer K; Moll M; Ljunggren H-G; Michaëlsson J; Sandberg JK
Article: PLOS ONE. 2011;6(4):e18779

Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.

Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
Article: JOURNAL OF IMMUNOLOGY. 2009;183(10):6612-6618

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.

Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren H-G; Alaeus A; Sandberg JK
Article: JOURNAL OF VIROLOGY. 2009;83(21):11407-11411

High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.

Gonzalez VD; Falconer K; Blom KG; Reichard O; Mørn B; Laursen AL; Weis N; Alaeus A; Sandberg JK
Visa fler

Alla övriga publikationer

Letter: LANCET MICROBE. 2023;4(7):e488

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.

Bladh O; Marking U; Havervall S; Norin NG; Aguilera K; Hober S; Smed-Sörensen A; Gordon M; Blom K; Åberg M; Klingström J; Thålin C
Letter: LANCET INFECTIOUS DISEASES. 2023;23(2):150-152

7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection.

Marking U; Bladh O; Havervall S; Svensson J; Greilert-Norin N; Aguilera K; Kihlgren M; Salomonsson A-C; Månsson M; Gallini R; Kriegholm C; Bacchus P; Hober S; Gordon M; Blom K; Smed-Sörensen A; Åberg M; Klingström J; Thålin C
Letter: THE LANCET REGIONAL HEALTH - EUROPE. 2023;24:100564

Rapid emergence of omicron sublineages expressing spike protein R346T.

Groenheit R; Galanis I; Sondén K; Sperk M; Movert E; Bacchus P; Efimova T; Petersson L; Rapp M; Sahlén V; Söderholm S; Valentin Asin K; Zanetti S; Lind Karlberg M; Bråve A; Klingström J; Blom K
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(14):1333-1336

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.

Havervall S; Marking U; Svensson J; Greilert-Norin N; Bacchus P; Nilsson P; Hober S; Gordon M; Blom K; Klingström J; Åberg M; Smed-Sörensen A; Thålin C
Letter: EMERGING INFECTIOUS DISEASES. 2022;28(10):2119-2121

Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022.

Blom K; Havervall S; Marking U; Norin NG; Bacchus P; Groenheit R; Bråve A; Thålin C; Klingström J
Letter: LANCET INFECTIOUS DISEASES. 2022;22(7):943-945

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.

Blom K; Marking U; Havervall S; Norin NG; Gordon M; García M; Tecleab T; Christ W; Forsell M; Phillipson M; Nilsson P; Mangsbo S; Hober S; Åberg M; Klingström J; Thålin C
Review: FRONTIERS IN IMMUNOLOGY. 2018;9:2174

Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection.

Blom K; Cuapio A; Sandberg JT; Varnaite R; Michaëlsson J; Björkström NK; Sandberg JK; Klingström J; Lindquist L; Gredmark Russ S; Ljunggren H-G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2017;282(3):206-208

Prospects for induction of CD8 T cell-mediated immunity to Zika virus infection by yellow fever virus vaccination.

Blom K; Sandberg JT; Loré K; Ljunggren H-G
KI thesis / dissertation: 2016

Cell-mediated immunity to flavivirus infections

Blom, Kim

Anställningar

Anknuten till Forskning, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2022-2024

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2016

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI